![Nitin Gore](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Nitin Gore
Keine laufenden Positionen mehr
Profil
Nitin Gore worked as a Principal at Wockhardt Ltd., a Controller at Emcure Pharmaceuticals Ltd., and a Chief Quality Officer at RPG Life Sciences Ltd.
He received his undergraduate, graduate, and doctorate degrees from the University of Mumbai.
Ehemalige bekannte Positionen von Nitin Gore
Unternehmen | Position | Ende |
---|---|---|
WOCKHARDT LIMITED | Corporate Officer/Principal | - |
RPG LIFE SCIENCES LIMITED | Corporate Officer/Principal | - |
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Comptroller/Controller/Auditor | - |
Ausbildung von Nitin Gore
University of Mumbai | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
WOCKHARDT LIMITED | Health Technology |
RPG LIFE SCIENCES LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Emcure Pharmaceuticals Ltd.
![]() Emcure Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Emcure Pharmaceuticals Ltd. engages in developing, manufacturing and marketing of pharmaceutical products. Its products include Nucron, Xennea, Xennex, Nifirex, Criante and Oncocare. The company offers calcium channel blockers, beta blockers, hypotensive combinations, statins, anti-coagulants, and diuretic combinations for cardiology. Its product portfolio includes orals, injectable and biologics, as well as an mRNA platform through which it is developing a COVID-19 vaccine. The company was founded by Satish Ramanlal Mehta on April 16, 1981 and is headquartered in Pune, India. | Health Technology |